RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,419 | -54.2% | 8,290 | -55.2% | 0.00% | -60.0% |
| Q2 2023 | $138,330 | +138230.0% | 18,518 | +23.9% | 0.01% | +66.7% |
| Q1 2023 | $100 | +455.6% | 14,944 | +550.0% | 0.00% | +200.0% |
| Q4 2022 | $18 | -100.0% | 2,299 | -85.1% | 0.00% | -66.7% |
| Q3 2022 | $164,000 | +320.5% | 15,411 | +223.6% | 0.00% | +200.0% |
| Q2 2022 | $39,000 | +85.7% | 4,762 | +62.1% | 0.00% | – |
| Q1 2022 | $21,000 | -70.0% | 2,938 | -28.5% | 0.00% | -100.0% |
| Q4 2021 | $70,000 | +400.0% | 4,109 | +607.2% | 0.00% | – |
| Q3 2021 | $14,000 | -84.6% | 581 | -76.9% | 0.00% | -100.0% |
| Q2 2021 | $91,000 | – | 2,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $16,889,000 | 37.30% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $31,958,000 | 5.87% |
| Yong Rong (HK) Asset Management Ltd | 377,000 | $8,675,000 | 5.69% |
| Samsara BioCapital, LLC | 752,939 | $17,325,000 | 2.72% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $34,728,000 | 2.04% |
| Spouting Rock Asset Management, LLC | 52,851 | $1,216,000 | 0.61% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 661,703 | $15,226,000 | 0.43% |
| Laurion Capital Management LP | 3,923,713 | $90,285,000 | 0.38% |
| Casdin Capital, LLC | 548,156 | $12,613,000 | 0.31% |
| Baillie Gifford | 22,061,374 | $507,632,000 | 0.27% |